carbidopa / levodopa

RxCUI
103990
RxNorm name
carbidopa / levodopa
Term type
MIN
Status
Active
Updated
2026-11-06 11:35:53

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042005
Active start
092010
Multiple ingredient
YES
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
carbidopa2019
levodopa6375

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRcarbidopa / levodopa1NAMES
RxNorm Namecarbidopa / levodopa1NAMES
TTYMIN1ATTRIBUTES
RxCUI1039901CODES
MMSL_CODE
2 linked values
2CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN04BADopa and dopa derivativesATC1-4levodopa
FDASPLD024322Amino Acids, AromaticCHEMhas_chemical_structurelevodopa
FDASPLN0000193220Aromatic Amino AcidEPChas_epclevodopa
FDASPLN0000175754Aromatic Amino Acid Decarboxylation InhibitorEPChas_epccarbidopa
FDASPLN0000175755DOPA Decarboxylase InhibitorsMOAhas_moacarbidopa
MEDRTD002230CarbidopaCHEMhas_ingredientcarbidopa
MEDRTD007980LevodopaCHEMhas_ingredientlevodopa
MEDRTD004342Drug HypersensitivityDISEASEci_withcarbidopa
MEDRTD004342Drug HypersensitivityDISEASEci_withlevodopa
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withcarbidopa
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withlevodopa
MEDRTD008545MelanomaDISEASEci_withcarbidopa
MEDRTD008545MelanomaDISEASEci_withlevodopa
MEDRTD010300Parkinson DiseaseDISEASEmay_treatfoscarbidopa
MEDRTD010300Parkinson DiseaseDISEASEmay_treatcarbidopa
MEDRTD010300Parkinson DiseaseDISEASEmay_treatfoslevodopa
MEDRTD010300Parkinson DiseaseDISEASEmay_treatlevodopa
MEDRTN0000175755DOPA Decarboxylase InhibitorsMOAhas_moafoscarbidopa
MEDRTN0000000203Dopamine Receptor InteractionsMOAhas_moacarbidopa
MEDRTN0000000203Dopamine Receptor InteractionsMOAhas_moalevodopa
MEDRTN0000000203Dopamine Receptor InteractionsMOAhas_moafoslevodopa
MEDRTN0000000203Dopamine Receptor InteractionsMOAhas_moafoscarbidopa
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacarbidopa
MEDRTN0000000133Enzyme InhibitorsMOAhas_moafoscarbidopa
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moacarbidopa
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moafoslevodopa
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moalevodopa
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moafoscarbidopa
MEDRTN0000009183Increased Central Nervous System Dopamine ActivityPEhas_pefoslevodopa
MEDRTN0000009183Increased Central Nervous System Dopamine ActivityPEhas_pefoscarbidopa
MEDRTN0000009183Increased Central Nervous System Dopamine ActivityPEhas_pelevodopa
MEDRTN0000009183Increased Central Nervous System Dopamine ActivityPEhas_pecarbidopa

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESRXNAV_HUMAN_DRUGUS
CODESSNOMEDCT404830004
CODESVUID4022149
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File